Omega Healthcare Investors, Inc. (NYSE:OHI) Receives $46.82 Average Target Price from Brokerages

Shares of Omega Healthcare Investors, Inc. (NYSE:OHIGet Free Report) have been given an average rating of “Moderate Buy” by the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $46.8182.

Several equities research analysts recently issued reports on the company. Royal Bank Of Canada boosted their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company a “sector perform” rating in a research note on Thursday, November 6th. Truist Financial upped their target price on Omega Healthcare Investors from $44.00 to $46.00 and gave the company a “hold” rating in a research report on Monday, December 1st. Scotiabank increased their target price on Omega Healthcare Investors from $42.00 to $45.00 and gave the stock a “sector perform” rating in a report on Thursday, November 13th. Wells Fargo & Company downgraded Omega Healthcare Investors from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $48.00 to $45.00 in a research note on Thursday, January 29th. Finally, Citigroup reaffirmed a “buy” rating and set a $50.00 price objective (up previously from $45.00) on shares of Omega Healthcare Investors in a research report on Wednesday, November 12th.

Get Our Latest Report on OHI

Omega Healthcare Investors Stock Up 0.0%

OHI opened at $42.94 on Monday. Omega Healthcare Investors has a fifty-two week low of $35.04 and a fifty-two week high of $46.36. The company has a debt-to-equity ratio of 0.95, a quick ratio of 7.11 and a current ratio of 7.11. The company has a market capitalization of $12.69 billion, a P/E ratio of 23.99, a P/E/G ratio of 1.38 and a beta of 0.57. The stock has a fifty day moving average of $44.43 and a 200-day moving average of $42.58.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last released its quarterly earnings results on Wednesday, February 4th. The real estate investment trust reported $0.80 EPS for the quarter, beating the consensus estimate of $0.79 by $0.01. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. During the same period in the prior year, the firm earned $0.74 EPS. Omega Healthcare Investors’s quarterly revenue was up 13.3% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.150-3.250 EPS. On average, equities analysts expect that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Monday, February 9th will be issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date is Monday, February 9th. Omega Healthcare Investors’s dividend payout ratio is presently 149.72%.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada increased its holdings in shares of Omega Healthcare Investors by 29.4% during the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock valued at $5,496,000 after acquiring an additional 32,798 shares in the last quarter. Focus Partners Wealth grew its position in shares of Omega Healthcare Investors by 3.1% during the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock valued at $756,000 after acquiring an additional 597 shares during the period. Sivia Capital Partners LLC purchased a new position in shares of Omega Healthcare Investors during the 2nd quarter valued at $257,000. 111 Capital purchased a new stake in Omega Healthcare Investors during the second quarter valued at about $803,000. Finally, DAVENPORT & Co LLC boosted its holdings in Omega Healthcare Investors by 10.4% in the 2nd quarter. DAVENPORT & Co LLC now owns 12,740 shares of the real estate investment trust’s stock worth $467,000 after buying an additional 1,197 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Featured Stories

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.